NLM Logo

pralsetinib MeSH Supplementary Concept Data 2025


MeSH Supplementary
pralsetinib
Unique ID
C000655704
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000655704
Entry Term(s)
BLU-667
Cyclohexanecarboxamide, N-((1S)-1-(6-(4-fluoro-1H-pyrazol-1-yl)-3-pyridinyl)ethyl)-1-methoxy-4-(4-methyl-6-((5-methyl-1H-pyrazol-3-yl)amino)-2-pyrimidinyl)-, trans-
gavreto
trans-N-((1S)-1-(6-(4-Fluoro-1H-pyrazol-1-yl)-3-pyridinyl)ethyl)-1-methoxy-4-(4-methyl-6-((5-methyl-1H-pyrazol-3-yl)amino)-2-pyrimidinyl)cyclohexanecarboxamide
Pharm Action
Antineoplastic Agents
Registry Numbers
0
Heading Mapped to
*Pyrazoles
*Pyridines
*Pyrimidines
Frequency
48
Note
RET inhibitor
Source
Cancer Discov. 2018 Jul;8(7):836-849.
Date of Entry
2019/12/16
Revision Date
2021/07/21
pralsetinib Preferred
BLU-667 Narrower
trans-N-((1S)-1-(6-(4-Fluoro-1H-pyrazol-1-yl)-3-pyridinyl)ethyl)-1-methoxy-4-(4-methyl-6-((5-methyl-1H-pyrazol-3-yl)amino)-2-pyrimidinyl)cyclohexanecarboxamide Broader
gavreto Narrower
page delivered in 0.007s